ESLAW
Estrella Immunopharma, Inc. - Warrant (ESLAW)
$09
About Estrella Immunopharma, Inc. - Warrant (ESLAW)
Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies for patients with cancers and autoimmune diseases. The company was founded on March 30, 2022 and is headquartered in Emeryville, CA.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.19
52 Week Low
$0.03
Market cap
--
Dividend yield
0.00%
Volume
--
Avg. volume
416
P/E ratio
--
Estrella Immunopharma, Inc. - Warrant News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.19
52 Week Low
$0.03
Market cap
--
Dividend yield
0.00%
Volume
--
Avg. volume
416
P/E ratio
--